Skip to content

Effect of the order of lung tumor removal and lymph node dissection on circulating tumor cells during lung cancer surgery

A prospective observational study evaluating the influence of surgical sequence (lung-first versus lymph node-first) on perioperative circulating tumor cell dynamics in patients undergoing surgical resection for non-small cell lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN17981262
Enrollment
60
Registered
2026-03-10
Start date
2023-05-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resectable non-small cell lung cancer (NSCLC) Cancer

Interventions

This was a prospective, non-randomized, two-arm observational study including 60 patients with resectable non-small cell lung cancer undergoing surgical resection (May–December 2023). Participants wer

Sponsors

First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 80 years 2. Newly diagnosed primary lung malignancy confirmed as NSCLC by pathology or cytology 3. No previous malignant tumor in other organs 4. No distant metastasis on preoperative imaging 5. Adequate cardiac, hepatic, pulmonary and renal function 6. Written informed consent provided

Exclusion criteria

Exclusion criteria: 1. Age 80 years 2. Non-NSCLC lung tumors 3. Severe organ dysfunction or surgical contraindications 4. Autoimmune diseases or coagulation disorders 5. Previous malignant tumors 6. Refusal to participate or inability to provide informed consent

Countries

China

Contacts

Public ContactZou Guowen
guowenzou1988@163.com+86 (0)18070495050

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026